Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties
Pharmacist dispensed naloxone: Knowledge, availability, participation and cost in selected California counties
复制标题
DOI：
10.1016/j.drugpo.2019.06.001
复制
发表时间：
2019-09-01
影响因子：
4.4
通讯作者：
Armenian, Patil
中科院分区：
文献类型：
--
作者：
Darracq, Michael A.;Lee, Janelle;Armenian, Patil
背景：2014年，加利福尼亚州签署了AB1535法律，允许药剂师在没有医生或中级提供者处方的情况下按要求配发纳洛酮。目的：我们试图确定药剂师对AB1535的了解、参与情况、纳洛酮的可用性、未来的参与计划以及对消费者的自付费用。方法：确定普卢马斯、莱克、拉森、洪堡、沙斯塔、弗雷斯诺和圣地亚哥的所有药店。在2017年1月30日至3月30日期间，联系符合纳入标准的药房，询问值班药剂师纳洛酮的知识、参与度、可获得性和费用。结果：7个县共确定2296家药店。26人不愿或无法参加，另有1648人因许可证或特殊药房身份而被排除在外。622家药店完成了调查。在AB1535的知识、参与、纳洛酮的即时可获得性、费用以及表示未来参与的兴趣确定方面存在差异。接受调查的县内药店对消费者的收费也有类似的变化。结论：尽管有相当大的公共卫生和政治支持，CA AB1535的通过并没有导致广泛的当前和未来的计划参与，也没有在选定的县获得纳洛酮的供应。消费者的自付成本仍然非常不稳定。
Background: In 2014, California signed into law AB1535 permitting pharmacists to dispense naloxone upon request and without physician or midlevel provider prescription.Objective: We sought to determine pharmacist knowledge of AB1535, participation, availability of naloxone, future plans for participation, and out-of-pocket charges to consumers amongst outpatient pharmacies in selected California counties.Methods: All pharmacies in Plumas, Lake, Lassen, Humboldt, Shasta, Fresno, and San Diego Counties were identified. Between January 30 and March 30, 2017, pharmacies meeting inclusion criteria were contacted and the pharmacist-on-duty were queried regarding knowledge, participation, availability, and cost of naloxone.Results: A total of 2296 pharmacies were identified in the 7 counties. Twenty-six were unwilling or unable to participate and an additional 1648 were excluded because of licensing or special pharmacy status. Six-hundred-twenty-two pharmacies completed the survey. There was variation in knowledge of AB1535, participation in, immediate availability of naloxone, charge, and expressed future interest in participation identified. Charge to consumers was similarly variable amongst surveyed pharmacies within counties.Conclusions: Despite considerable public health and political support, the passage of CA AB1535 has not resulted in broad current, future planned participation, or availability of naloxone in selected counties. Out-of-pocket costs to the consumer remain highly variable.